Abstract
Regenerative MedicineVol. 11, No. 4 Industry NewsLatest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions 1 January–29 February 2016Dusko Ilic & Oliver BallDusko Ilic*Author for correspondence: E-mail Address: dusko.ilic@kcl.ac.uk Stem Cell Laboratories, Guy's Assisted Conception Unit, Division of Women's Health, King's College London School of Medicine, London, UKSearch for more papers by this author & Oliver Ball Stem Cell Laboratories, Guy's Assisted Conception Unit, Division of Women's Health, King's College London School of Medicine, London, UKSearch for more papers by this authorPublished Online:11 May 2016https://doi.org/10.2217/rme-2016-0027AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReference1 Carter MG, Smagghe BJ, Stewart AK et al. A primitive growth factor, NME7AB, is sufficient to induce stable naïve state human pluripotency; reprogramming in this novel growth factor confers superior differentiation. Stem Cells 36, 847–859 (2016).Crossref, Google ScholarFiguresReferencesRelatedDetails Vol. 11, No. 4 Follow us on social media for the latest updates Metrics Downloaded 158 times History Published online 11 May 2016 Published in print June 2016 Information© Future Medicine LtdPDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
